Market Place
Sourcing Support
Metagenomi Reports Business Updates & Q3 2024 Financial Results
13 Nov 2024 //
GLOBENEWSWIRE
Metagenomi Presents Preclinical Hemophilia A Data at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Metagenomi Presents Novel Adenine Base Editors For Genome Editing
24 Oct 2024 //
GLOBENEWSWIRE
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th
14 Oct 2024 //
GLOBENEWSWIRE
Metagenomi To Present At Chardan`s Genetic Medicines Event
19 Sep 2024 //
GLOBENEWSWIRE
Metagenomi Lead Hemophilia A Program Shows 12-Month Durable FVIII Levels
03 Sep 2024 //
GLOBENEWSWIRE
Metagenomi Presents AI-Enabled SMART Editing Advancements at CRISPR Conference
29 Aug 2024 //
GLOBENEWSWIRE
Metagenomi to Participate in Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
14 Aug 2024 //
GLOBENEWSWIRE
Metagenomi axes ALS program after seeing Biogen and Ionis flounder
14 Aug 2024 //
FIERCE BIOTECH
Delve Bio Announces Data On mNGS For Identifying Pathogens In CNS Infections
17 Jun 2024 //
BUSINESSWIRE
Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
29 May 2024 //
GLOBENEWSWIRE
Metagenomi Presents Data, Q1 2024 Financial Results
14 May 2024 //
GLOBENEWSWIRE
Metagenomi Regains Full Rights To Base Editing, RIGS Platforms
01 May 2024 //
GLOBENEWSWIRE
Clinical Microbiomics Launches Advanced Sequencing Services
23 Apr 2024 //
PR NEWSWIRE
Metagenomi to Present at Upcoming Scientific Meetings
08 Apr 2024 //
GLOBENEWSWIRE
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
27 Mar 2024 //
GLOBENEWSWIRE
Metagenomi Announces Closing of Initial Public Offering
13 Feb 2024 //
GLOBENEWSWIRE
Metagenomi, Telomir offer double test case for preclinical IPOs
09 Feb 2024 //
FIERCE BIOTECH
Metagenomi Announces Pricing of Initial Public Offering
08 Feb 2024 //
GLOBENEWSWIRE
Gene editing biotech Metagenomi plans modest $87M IPO
05 Feb 2024 //
FIERCE BIOTECH
Metagenomi, Arrivent to sneak through crack in IPO window
07 Jan 2024 //
FIERCE BIOTECH
Metagenomi submits IPO paperwork in third planned biotech listing of 2024
05 Jan 2024 //
ENDPTS
Metagenomi Appoints Luis Borges, Ph.D., as Chief Scientific Officer
09 Nov 2023 //
BUSINESSWIRE
Metagenomi Presents New Data on Novel Gene Editing Systems at ASGCT
19 May 2023 //
BUSINESSWIRE
Metagenomi to Present New Data for Its Novel Gene-Editing Systems at (ASGCT)
02 May 2023 //
BUSINESSWIRE
Metagenomi Recognized as World’s Most Innovative Companies by Fast Company
02 Mar 2023 //
BUSINESSWIRE
Metagenomi to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
BUSINESSWIRE
Metagenomi Announces Publication of Data in Nature Communications Novel
15 Dec 2022 //
BUSINESSWIRE
Ionis partners up with Metagenomi on drug discovery pact, shelling out $80M
15 Nov 2022 //
ENDPTS
Metagenomi Announces Opening of Manufacturing Facility for CRISPR
11 Oct 2022 //
BUSINESSWIRE
After roping in $175M+, Metagenomi opens the doors to a new manufacturing site
11 Oct 2022 //
ENDPTS
Metagenomi Announces Participation in October Investor and Industry Conferences
03 Oct 2022 //
BUSINESSWIRE
Metagenomi Announces Participation in Investor and Industry Conferences
06 Sep 2022 //
BUSINESSWIRE
Affini-T & Metagenomi Announce Next-Generation Gene Editing Partnership
15 Jun 2022 //
BUSINESSWIRE
Metagenomi to Present New Preclinical Data at the Upcoming ASGCT
05 May 2022 //
BUSINESSWIRE
Metagenomi Presents Findings on Novel Families of Ultra Small, CRISPR Enzymes
03 May 2022 //
BUSINESSWIRE
Metagenomi to Present at the Longwood Healthcare Leaders Spring Webconference
28 Apr 2022 //
BUSINESSWIRE
Metagenomi to Present at Upcoming Investor Conferences
24 Mar 2022 //
BUSINESSWIRE
Metagenomi Appoints Christine Foster as CBO, and Alan H. Cohen as CMO & SVP
15 Mar 2022 //
BUSINESSWIRE
Gene editing startup Metagenomi raises $175M to advance research pipeline
25 Jan 2022 //
BIOPHARMADIVE
Moderna tries its hand at CRISPR through a new development pact with Metagenomi
02 Nov 2021 //
ENDPTS
Metagenomi Announces Participation in Fall Investor Conferences
02 Sep 2021 //
BUSINESSWIRE
Bayer-backed Metagenomi bumps up series A to $75M
07 Apr 2021 //
FIERCEBIOTECH
Metagenomi Extends Series A Financing from RA Capital and Welcomes
06 Apr 2021 //
BUSINESSWIRE
Bayer leads Metagenomi complete $65M series A financing round
13 Nov 2020 //
BIOSPECTRUMASIA
Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer
12 Nov 2020 //
BUSINESSWIRE
